{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:51Z","timestamp":1781650791682,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05851-4","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:34:39Z","timestamp":1776915279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atrial fibrillation recurrence after rhythm control: gaps in outpatient risk factor management in a single-centre retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"D.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Graby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.L.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Khavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"5851_CR1","unstructured":"British Heart Foundation. Heart & circulatory disease statistics 2025 compendium. London: BHF. 2025. Available from: https:\/\/www.bhf.org.uk\/what-we-do\/our-research\/heart-statistics\/heart-statistics-publications\/cardiovascular-disease-statistics-2025. Cited 2025 Jul 1."},{"issue":"5","key":"5851_CR2","doi-asserted-by":"publisher","first-page":"e4481","DOI":"10.1016\/j.amjmed.2005.10.057","volume":"119","author":"G Thrall","year":"2006","unstructured":"Thrall G, Lane D, Carroll D, Lip GYH. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119(5):e4481\u201319. https:\/\/doi.org\/10.1016\/j.amjmed.2005.10.057.","journal-title":"Am J Med"},{"issue":"18","key":"5851_CR3","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","volume":"119","author":"E Anter","year":"2009","unstructured":"Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516\u201325. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.821306.","journal-title":"Circulation"},{"issue":"10046","key":"5851_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","volume":"388","author":"B Freedman","year":"2016","unstructured":"Freedman B, Potpara TS, Lip GYH. Stroke prevention in atrial fibrillation. Lancet. 2016;388(10046):806\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(16)31257-0.","journal-title":"Lancet"},{"issue":"10","key":"5851_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946\u201352. https:\/\/doi.org\/10.1161\/01.CIR.98.10.946.","journal-title":"Circulation"},{"issue":"2","key":"5851_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ehjqcco\/qcaa093","volume":"8","author":"P Burdett","year":"2022","unstructured":"Burdett P, Lip GYH. Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes. 2022;8(2):187\u201394. https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa093.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"2","key":"5851_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4022\/jafib.849","volume":"6","author":"AJ Shah","year":"2013","unstructured":"Shah AJ, Hocini M, Komatsu Y, Daly M, Zellerhoff S, Jesel L, et al. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. J Atr Fibrillation. 2013;6(2):849. https:\/\/doi.org\/10.4022\/jafib.849.","journal-title":"J Atr Fibrillation"},{"issue":"9","key":"5851_CR8","doi-asserted-by":"publisher","first-page":"euae204","DOI":"10.1093\/europace\/euae204","volume":"26","author":"A Goette","year":"2024","unstructured":"Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera JA, Chugh SS, et al. Atrial cardiomyopathy revisited\u2014evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. 2024;26(9):euae204. https:\/\/doi.org\/10.1093\/europace\/euae204.","journal-title":"Europace"},{"issue":"3","key":"5851_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jama.2023.23456","volume":"331","author":"JS Steinberg","year":"2024","unstructured":"Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: The ERADICATE-AF randomized clinical trial. JAMA. 2024;331(3):281\u20139. https:\/\/doi.org\/10.1001\/jama.2023.23456.","journal-title":"JAMA"},{"issue":"4","key":"5851_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/01.CIR.0000134469.15644.00","volume":"110","author":"AS Gami","year":"2004","unstructured":"Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364\u20137. https:\/\/doi.org\/10.1161\/01.CIR.0000134469.15644.00.","journal-title":"Circulation"},{"issue":"3","key":"5851_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/jebm.12313","volume":"11","author":"S Congrete","year":"2018","unstructured":"Congrete S, Bintvihok M, Thongprayoon C, Bathini T, Boonpheng B, Sharma K, et al. Effect of obstructive sleep apnea and its treatment of atrial fibrillation recurrence after radiofrequency catheter ablation: A meta-analysis. J Evid Based Med. 2018;11(3):145\u201351. https:\/\/doi.org\/10.1111\/jebm.12313.","journal-title":"J Evid Based Med"},{"issue":"20","key":"5851_CR12","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1161\/01.CIR.0000068337.25994.21","volume":"107","author":"R Kanagala","year":"2003","unstructured":"Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589\u201394. https:\/\/doi.org\/10.1161\/01.CIR.0000068337.25994.21.","journal-title":"Circulation"},{"key":"5851_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","volume":"90","author":"I Russo","year":"2016","unstructured":"Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016;90:84\u201393. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.12.011.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"5851_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","volume":"108","author":"RR Huxley","year":"2011","unstructured":"Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011;108(1):56\u201362. https:\/\/doi.org\/10.1016\/j.amjcard.2011.03.004.","journal-title":"Am J Cardiol"},{"issue":"2","key":"5851_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/heartjnl-2011-300963","volume":"98","author":"RR Huxley","year":"2012","unstructured":"Huxley RR, Alonso A, Lopez FL, Filion KB, Agarwal SK, Loehr LR, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis Risk in Communities study. Heart. 2012;98(2):133\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2011-300963.","journal-title":"Heart"},{"issue":"20","key":"5851_CR16","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","volume":"292","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Parise H, Levy D, D\u2019Agostino RB, Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471\u20137. https:\/\/doi.org\/10.1001\/jama.292.20.2471.","journal-title":"JAMA"},{"issue":"20","key":"5851_CR17","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2015.02.077","volume":"65","author":"RK Pathak","year":"2015","unstructured":"Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159\u201369. https:\/\/doi.org\/10.1016\/j.jacc.2015.02.077.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"5851_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/eurheartj\/ehz784","volume":"41","author":"ME Middeldorp","year":"2020","unstructured":"Middeldorp ME, Pathak RK, Meredith M, Mehta AB, Elliott AD, Mahajan R, et al. PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. Eur Heart J. 2020;41(11):1401\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehz784.","journal-title":"Eur Heart J"},{"issue":"19","key":"5851_CR19","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1001\/jama.2013.280815","volume":"310","author":"HS Abed","year":"2013","unstructured":"Abed HS, Wittert GA, Leong DP, Shirazi M, Bahrami B, Middeldorp M, et al. Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial. JAMA. 2013;310(19):2050\u201360. https:\/\/doi.org\/10.1001\/jama.2013.280815.","journal-title":"JAMA"},{"issue":"35","key":"5851_CR20","doi-asserted-by":"publisher","first-page":"ehae176","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"P Kirchhof","year":"2024","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(35):ehae176. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"issue":"1","key":"5851_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12872-022-02819-6","volume":"22","author":"S Klaveb\u00e4ck","year":"2022","unstructured":"Klaveb\u00e4ck S, Svennberg E, Nymark C, Braunschweig F, Lidin M. Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective. BMC Cardiovasc Disord. 2022;22(1):354. https:\/\/doi.org\/10.1186\/s12872-022-02819-6.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"5851_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/europace\/euac070","volume":"24","author":"MT Mills","year":"2022","unstructured":"Mills MT, Futyma P, Calvert P, Penela D, Roten L, Perrotta L, et al. Lifestyle and risk factor modification in atrial fibrillation: a European Heart Rhythm Association survey. Europace. 2022;24(7):1135\u201343. https:\/\/doi.org\/10.1093\/europace\/euac070.","journal-title":"Europace"},{"key":"5851_CR23","unstructured":"NHS Health Research Authority. Decision tools \u2013 Is my study research? Published 2020. Available from: http:\/\/hra-decisiontools.org.uk\/research."},{"key":"5851_CR24","volume-title":"Hypertension in adults: diagnosis and management","author":"NICE guideline NG136","year":"2019","unstructured":"NICE guideline NG136. Hypertension in adults: diagnosis and management. London: National Institute for Health and Care Excellence; 2019. [updated 2023]."},{"key":"5851_CR25","unstructured":"NICE. Type 2 diabetes: prevention in people at high risk. Public health guideline [PH38]. London: National Institute for Health and Care Excellence; 2012. Available from: https:\/\/www.nice.org.uk\/guidance\/ph38. Last updated 15 Sep 2017."},{"key":"5851_CR26","unstructured":"Chief Medical Officers (CMOs). UK Chief Medical Officers\u2019 Low Risk Drinking Guidelines. London: Department of Health and Social Care. 2016. Available from: https:\/\/www.gov.uk\/government\/publications\/alcohol-consumption-advice-on-low-risk-drinking."},{"issue":"21","key":"5851_CR27","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","volume":"64","author":"RK Pathak","year":"2014","unstructured":"Pathak RK, Middeldorp ME, Lau DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST AF cohort study. J Am Coll Cardiol. 2014;64(21):2222\u201331. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.028.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5851_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","volume":"66","author":"RK Pathak","year":"2015","unstructured":"Pathak RK, Elliott AD, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: The CARDIO FIT Study. J Am Coll Cardiol. 2015;66(9):985\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2015.06.488.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"5851_CR29","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3390\/diagnostics15162003","volume":"15","author":"R Gerculy","year":"2025","unstructured":"Gerculy R, Benedek I, Kov\u00e1cs I, Rat N, Rodean IP, M\u00e1ty\u00e1s B, et al. Coronary artery inflammation and epicardial adipose tissue volume in relation with atrial fibrillation development. Diagnostics (Basel). 2025;15(16):2003. https:\/\/doi.org\/10.3390\/diagnostics15162003.","journal-title":"Diagnostics (Basel)"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05851-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05851-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05851-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:36:06Z","timestamp":1781649366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05851-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5851"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05851-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved a retrospective review of clinical documentation only. According to the UK Health Research Authority (HRA) decision tool, the project was classified as a service evaluation and therefore did not require review by a Research Ethics Committee or formal ethical approval [\n                      \n                      ]. The study was registered as a service evaluation with the Trust\u2019s audit department, which confirmed that formal written informed consent from participants was not required. The study was conducted in accordance with the principles of the Declaration of Helsinki. Patients and members of the public were not involved in the design, conduct, reporting, or dissemination of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"482"}}